Items tagged with Diagnostics
From total neglect till a few years ago, childhood TB is now taking centrestage. A couple of days back, the WHO released an updated guidance for national TB programmes (NTPs) on the management of tuberculosis in children.
The identification of a distinct genetic ‘signature’ in the blood of infected children could turn around notoriously poor TB diagnosis rates, say an international body of scientists.
FORT COLLINS - Tuberculosis researchers at Colorado State University have landed a grant from the Bill and Melinda Gates Foundation to develop a diagnostic breath test with potential to revolutionize TB testing and to better control the globally devastating infectious disease.
Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings? (post)
Two rapid TB diagnostic tests had greater sensitivity in diagnosing tuberculosis in HIV-positive Ugandan, according to results of a 103-patient study. Sensitivity of the combined tests approached that of sputum liquid culture testing.
SomaLogic, Inc., announced today that it has received additional funding from the Bill & Melinda Gates Foundation to further develop and validate a SOMAmer-based tuberculosis (TB) biomarker assay for the accurate identification of persons with active TB. This new funding recognizes and extends the successful work completed under the initial TB biomarkers grant awarded to SomaLogic in January 2012 through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program.
The Department of Health’s multi-million rand investment in an automated, rapid TB test is being short-changed by slow health systems, said researchers this week.
A new test for tuberculosis (TB) could dramatically improve the speed and accuracy of diagnosis for one of the world’s deadliest diseases, enabling health care providers to report results to patients within minutes, according to a study published this week in the journal Angewandte Chemie.
A new study led by Johns Hopkins Bloomberg School of Public Health researchers suggests that getting patients in India quickly evaluated by the right doctors can be just as effective at curbing tuberculosis (TB) as a new, highly accurate screening test.
Epistem Holdings Plc (Epistem), the personalised medicine and biotechnology company, announced that it has entered into a collaborative funding agreement with the Global Health Investment Fund I, LLC (GHIF) to support the roll-out of its Genedrive® molecular diagnostic platform as the company's tuberculosis assay enters pivotal field trials in key developing world locations.
Page 3 of 49 · Total posts: 0←First 2 3 4 Last→